Moderna (MRNA) has had the highest return since June 1, 2026 by a large-cap US stock, returning 359.4%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 359.42% |
Twist Bioscience (TWST) | 126.3% |
PBF Energy (PBF) | 119.97% |
Everpure (P) | 101.11% |
Xp (XP) | 93.47% |
Frontline (FRO) | 90.17% |
Marathon Petroleum (MPC) | 89.29% |
Valero Energy (VLO) | 84.4% |
Atlassian (TEAM) | 82.2% |
HF Sinclair (DINO) | 81.67% |
Natera (NTRA) | 79.17% |
Okta (OKTA) | 76.55% |
Avantor (AVTR) | 73.36% |
Corcept Therapeutics (CORT) | 70.01% |
Illumina (ILMN) | 68.59% |
Paycom Software (PAYC) | 67.05% |
Charles River Laboratories (CRL) | 65.86% |
Halozyme Therapeutics (HALO) | 65.56% |
Phillips 66 (PSX) | 65.33% |
Veeva Systems Inc Class A (VEEV) | 65.06% |
Chime Financial, Inc Class A Common Stock (CHYM) | 61.36% |
Zscaler (ZS) | 58.24% |
Zebra Technologies (ZBRA) | 58.18% |
Hewlett Packard Enterprise (HPE) | 56.6% |
SharkNinja (SN) | 56.56% |
Large-cap stocks are treated as having a market cap of $10B+.